Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
124,414,852
-
Share change
-
-10,256,474
-
Total reported value
-
$5,499,320,170
-
Put/Call ratio
-
40%
-
Price per share
-
$44.23
-
Number of holders
-
328
-
Value change
-
-$444,927,599
-
Number of buys
-
138
-
Number of sells
-
172
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q3 2022
As of 30 Sep 2022,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
328 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,414,852 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, ARK Investment Management LLC, and BVF INC/IL.
This page lists
332
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.